Abstract
G-Protein-coupled receptors play an instrumental role in cellular development and function. In the mature organism, receptor signaling is controlled through the processes of desensitization and down-regulation. Recent evidence suggests that these regulatory mechanisms are not inherent properties, however, but rather are acquired during ontogenesis. This review focuses on β-adrenoceptors (βARs), which are found in fetal and neonatal tissues and are effectively linked through adenylyl cyclase (AC) to the production of cAMP. Agonist-induced stimulation of βARs in the immature organism fails to produce desensitization, and instead, responsiveness increases. The unique mechanisms underlying this anomalous response involve induction of AC, a switch to more catalytically efficient AC isoforms, an increase in the ratio of stimulatory to inhibitory G-proteins, and interference with the expression and/or function of other G-protein-linked receptors that provide offsetting, inhibitory inputs. These adjustments are thus heterologous, influencing signaling mediated by a host of other G-protein-coupled neurotransmitter and hormone receptors. The net effect is to maintain and augment βAR signaling in the face of continued stimulation, properties that disappear with maturation. The unique regulatory mechanisms for βAR signaling in the fetus and neonate provide the necessary physiological adjustments required for the perinatal transition from intrauterine to extrauterine life. At the same time, however, the inability to restrict βAR function may underlie adverse effects of βAR-agonist tocolytics that are used in the treatment of preterm labor.
Footnotes
-
This work was supported by U.S. Public Health Service Grants R01-HD09713 and T32-ES07031.
-
DOI: 10.1124/jpet.102.048421.
-
ABBREVIATIONS: βAR, β-adrenoceptor; AC, adenylyl cyclase; mAChR, muscarinic acetylcholine receptor; PN, postnatal day.
-
↵1 Present address: NIEHS, P.O. Box 12233, MD D2-04, 111 Alexander Dr., Research Triangle Park, NC 27709.
- Received March 7, 2003.
- Accepted April 4, 2003.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|